|
KMID : 1143620220260020032
|
|
Korean Journal of Nuclear Medicine Technology
2022 Volume.26 No. 2 p.32 ~ p.36
|
|
|
Discussion of COVID-19 Vaccination and Axillary Lymph Nodes Uptake in 18F-FDG PET/CT
|
|
Kim Min-Chan
Choi Yong-Hoon
Lim Han-Sang
Kim Jae-Sam
|
|
|
Abstract
|
|
|
Purpose: There are reports that the COVID-19 vaccine causes false positive uptake of axillary lymph nodes. Therefore,
this paper intends to evaluate the change in SUVmax of axillary lymph nodes with the period after the COVID-19 vaccination.
Materials and Methods: In 134 breast cancer patients who were tested for 18F-FDG PET/CT at Severance hospital, 3.7 MBq/kg of 18F-FDG was intravenously injected and scanned for 2 minutes per bed after 60 minutes. The equipment was Discovery 600 (GE Healthcare, MI, USA). The period was divided into four groups, 0 to 2 weeks, 3 to 6 weeks, 7 to 10 weeks, and 11 weeks or more. SUVmax was measured after checking the uptake of axillary lymph nodes on the ipsilateral side of vaccination and the Kruskal-Wallis test was performed using SPSS Statistics 28 (IBM Corp., Armonk, NY, USA).
Results: From 0 to 2 weeks groups to 11 weeks or more group, the average of SUVmax was measured in the order of 5.52,
2.85, 1.82, and 1.7. As a result of the Kruskal-Wallis test, there was a significant difference between 0 to 2 weeks group from all other groups (P < 0.05), and there was no significant difference between the remaining three groups.
Conclusion: The SUVmax of axillary lymph nodes decreased over the period after the COVID-19 vaccination and no significant difference was found after 3 weeks of vaccination. Therefore, it is recommended to record COVID-19 vaccination information before examination.
|
|
|
KEYWORD
|
|
|
Axillary lymph nodes, SUVmax, Vaccination
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|